drugset

drugset / Trial / NCT01983358

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

NCT01983358 ↗

Phase 1 Completed 40 enrolled Jeil Pharmaceutical Co., Ltd.

RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study in to evaluate safety, tolerability, pharmacokinetics of JPI-289 in healthy male subjects.

Timeline

Start: 2013-11
Primary completion: 2014-08
Completion: 2014-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AMELPARIB	Small molecule	—	Intravenous

Indications